Yourgene Health Cystic Fibrosis Assay Receives IVDR Accreditation
The Cystic Fibrosis Base assay has received IVDR accreditation, ensuring high standards for detecting cystic fibrosis mutations.
The Cystic Fibrosis Base assay has received IVDR accreditation, ensuring high standards for detecting cystic fibrosis mutations.
Sapphiros was selected by the NIH RADx Tech program to develop an over-the-counter, molecular multiplex respiratory diagnostic test.
Tech to advance the control of tuberculosis in areas with limited infrastructure has been approved by the Global Fund's Expert Review Panel for Diagnostics.Â
New research provides insights on the effects of cystic fibrosis in the kidneys, pointing to the potential for a urine test related to the disease.
Read MoreThe home saliva test also includes adenovirus, other coronaviruses, rhinovirus, parainfluenzas, pneumoniae, and other respiratory conditions.
Read MoreRoutine use of the positive run control enables laboratories to meet their individualized quality control goals, including evaluation of reagent lot changes and new shipments.
Read MoreNanoPin’s diagnostic platform using Thermo Fisher’s advanced LC-MS technology will create sensitive clinical assays for infectious disease.
Read MoreThe Pulmonary Fibrosis Foundation has announced a new collaboration that could speed up the development of targeted treatments for individuals with idiopathic pulmonary fibrosis.
Read MoreRoutine use of the EDX RP positive run control enables laboratories to meet the requirements of their individualized quality control plans, including evaluation of reagent lot changes and new shipments.
Read MoreThe panel tests nasopharyngeal swabs for the most common respiratory viruses and bacteria.
Read MoreThe test enables highly automated screening for latent tuberculosis.
Read MoreThe Headstart system is designed for home monitoring and integrates a simple, easy-to-use diagnostic with a reader and mobile phone app to capture patient-specific health data.
Read MoreIGeneX’s new BCA assays are simple and cost-effective tests that give either a positive or negative result for exposure to Borrelia spp.
Read MoreThe company will receive funding to provide the breath biopsy component of a research initiative designed to provide new insights into the mechanisms of response and nonresponse to treatment for seven immune-mediated diseases.
Read MorePositive and negative controls are designed to help laboratories deliver reliable MTB-RIF testing results.
Read MoreThe funding will enable Lophius to expand clinical performance data and finalize design of the assay for use on automated platforms.
Read MoreA study by Karolinska Institute researchers shows that an algorithm used in a mobile phone app can efficiently manage uncontrolled asthma.
Read MoreStudy subjects with uncontrolled asthma had substantially higher levels of local IL-26 in their airways, when compared with subjects with controlled asthma.
Read More